NUZ 6.25% 22.5¢ neurizon therapeutics limited

My understanding was final costs could only be fully assessed...

  1. 2,357 Posts.
    lightbulb Created with Sketch. 2950
    My understanding was final costs could only be fully assessed when protocol for our Regimen is signed off with Healey.
    Then it can be decided if the cofferers need to be topped up to cover Healey trial, working capital and anything else in the works.
    But we won't be that far short, no matter what the outcome from the assessment.

    However, I highly doubt that they will come to the ASX market for a top-up.
    No doubt they have been having a few conversations with entities in the USA that would like to get involved.
    If you want a piece of the PAA(NUX) action, I can't see how it gets any better than 15% below the CR price of offer today.

    All IMO of course, and definitely not investment advice !
 
watchlist Created with Sketch. Add NUZ (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.